DEF 14AThe Ballot
Niagen Bioscience, Inc. files DEF 14A
Filed Apr 27, 2018 · 8y ago · Accession 0001654954-18-004446
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Niagen Bioscience, Inc.
- Ticker
- NAGE
- CIK
- 1386570
- Form type
- DEF 14A
- Filing date
- Apr 27, 2018
- Report date
- Jun 22, 2018
- Document
- cdxcdef14_apr2018.htm
- Size
- 1.3 MB